Pharmaceutical companies call for more deregulation

Domestic drug manufacturers have asked the government to ease drug related regulations, such as scope of toll manufacturing and bioequivalence, and heavy fines.

In a recent meeting with officials from the Korea Food and Drug Administration, pharmaceutical chief executive officers demanded the comparative dissolution test data be acknowledged instead of bioequivalence data to save time and co...